Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers

8 Dec 2022

Abstract excerpt

Cluster of Differentiations 73 (CD73)/ecto-5'-nucleotidase (NT5E) is a novel type of immune molecular marker expressed on many tumor cells and involved in regulating the essential immune functions and affecting the prognosis of cancer patients. However, it is not clear how the NT5E is linked to the infiltration levels of the immune cells in pan-cancer patients and their final prognosis. This study explores the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine and Purinergic Signaling
Share to Cancer Immunotherapy and Biomarkers
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36480312
DOI: 10.1002/adbi.202200263

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD73/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of CancersPMID 36480312Read ↗

Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironmentSemantic proximity Read ↗

Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various CancersSemantic proximity Read ↗

Comprehensive Analysis of Prognosis and Immune Function of CD70-CD27 Signaling Axis in Pan-CancerSemantic proximity Read ↗

Comprehensive Analysis of DMRT3 as a Potential Biomarker Associated with the Immune Infiltration in a Pan-Cancer Analysis and Validation in Lung AdenocarcinomaSemantic proximity Read ↗

Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma.Semantic proximity Read ↗

Pan-cancer analysis of the glycoprotein - associated gene B4GALNT4 with prognositc value and immunological role in malignant tumorsSemantic proximity Read ↗

Effects of abnormal expression of CD73 on malignant phenotype in nasopharyngeal carcinomaSemantic proximity Read ↗

GPNMB expression impacts prognosis and immune infiltration in cancersSemantic proximity Read ↗

The epiphany derived from T-cell–inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responsesSemantic proximity Read ↗

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer typesSemantic proximity Read ↗

Comprehensive pan-cancer analysis of STAT3 as a prognostic and immunological biomarkerSemantic proximity Read ↗

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.